Shares of Dye & Durham Limited (Dye and Durham Stock Quote, Chart, News, Analysts, Financials TSX:DND) a provider of cloud-based legal practice management software, saw a significant rise on Monday, November 13.
The company’s stock on the Toronto Stock Exchange spiked, closing at CAD 12.15, up 12.5 per cent from the previous close of $10.80.
The company recently announced a strategic review of its “non-core” assets, aiming to expedite its deleveraging plan. This move is part of Dye & Durham’s broader strategy to reduce its leverage ratio and strengthen its financial position.
“Despite our strong business performance and liquidity position, we understand our shareholders would like us to reduce our leverage ratio,” CEO Matthew Proud said. “We strongly believe this strategic review will accelerate this process. We are working closely with our financial and legal advisers to ensure the review is comprehensive, diligent and maximizes value.”
DND has retained Goldman Sachs and Canaccord Genuity Corp. as financial advisers in the sale of its “non-core” assets.
Additionally, Dye & Durham commenced a substantial issuer bid, previously announced in October 2023. This initiative involves the repurchase for cancellation of up to CAD 95,000,000 of its issued and outstanding shares, highlighting the company’s efforts to improve its balance sheet flexibility.
These strategic decisions appear to have positively influenced investor confidence, reflected in the stock’s recent performance. With a market capitalization of CAD 668.25 million and a 52-week range of CAD 7.46 to CAD 23.14, Dye & Durham is navigating its financial and operational challenges with these significant corporate actions.
Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]
Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]
Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]
Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]
Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]
Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]